Neurosurgical products market poised for growth
Editor's Note
Wise Guy Reports predicts the global market for neurosurgical products will see a 10.5% compound annual growth rate through 2023 because of the growing availability of neurosurgical devices and increasing popularity of minimally invasive surgeries, the February 9 Becker’s Spine Review reports.
Key players in the market, which is led by the neurostimulation devices, are Boston Scientific, Medtronic, Stryker, DePuy Synthes, and Integra LifeSciences.
The global neurosurgical products market is anticipated to grow at a 10.5 percent compound annual growth rate through 2023, according to Wise Guy Reports. Here are five observations: 1. The neurostimulation devices segment is leading the market, due to the increasing supportive clinical data of the devices' safety and effectiveness.
Free Daily News
- Survey assesses continued impact of Change Healthcare cyberattack
- WHO sounds alarm on potential spread of bird flu
- Allison Massari to deliver hopeful, empowering keynote address at OR Manager Conference 2024
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession